PharmaResearch Co., Ltd. (214450.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap4.19T
Enterprise Value4.23T
P/E Ratio16.74
PEG Ratio0.29
Price/Sales Ratio5.23
Price/Book Ratio4.35
Enterprise/Revenue5.25
Enterprise/EBITDA12.49

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.31
Operating Margin0.4
AD

Management Effectiveness

Return On Assets0.16
Return On Equity0.27

Income Statement

Revenue535.72B
Revenue/Share53,063.37
Gross Profit402.43B
EBITDA228.14B
Net Income165.12B
Diluted EPS14,933

Balance Sheet

Total Cash630.78B
Total Cash/Share59,249.98
Total Debt214.44B
Total Debt/Equity0.31
Current Ratio5.69
Book Value Per Share68,802.95

Price History

52-Week Change-41.94
52-Week High713,000
52-Week Low255,000
Moving Average 50 Days305,800
Moving Average 200 Days409,072.5

Statistics

Average Volume89,179
Shares Outstanding10.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1,100
Trailing Annual Dividend Yield0.39
Payout Ratio0.06
Last Split FactorN/A
Last Split DateN/A
AD